Article Details

New addition to DFE Pharma excipients portfolio aids in stabilizing biologics

Retrieved on: 2021-05-18 11:47:12

Tags for this article:

Click the tags to see associated articles and topics

New addition to DFE Pharma excipients portfolio aids in stabilizing biologics. View article details on hiswai:

Excerpt

BioHale Sucrose is part of its new portfolio, BioHale, targeted at the biopharmaceutical manufacturing industry; the product, said to be low in endotoxin ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up